Testing effectiveness (Phase 2)Study completedNCT00043745What this trial is testingBone Response to Soy Isoflavones in WomenWho this might be right forOsteopeniaOsteoporosis Iowa State University 224
Testing effectiveness (Phase 2)Ended earlyNCT00807365What this trial is testingSix Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the ElderlyWho this might be right forElderly Johns Hopkins University 5
Not applicableLooking for participantsNCT06680401What this trial is testingEpithelioid Haemangioendothelioma Observational StudyWho this might be right forClinical PresentationNatural HistoryTreatment Outcomes Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 50
Not applicableActive Not RecruitingNCT04370522What this trial is testingCharacterization of Innate Immune System in Patients With Luminal Advanced Breast CancerWho this might be right forMetastatic Breast Cancer Spanish Breast Cancer Research Group 32
Not applicableNot Yet RecruitingNCT07501637What this trial is testingMind-Body Group Interventions for Psychological Distress in Young Breast Cancer SurvivorsWho this might be right forBreast Cancer University of Alabama at Birmingham 30
Not applicableStudy completedNCT01366053What this trial is testingHormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH AgonistsWho this might be right forProstate Cancer CMX Research 125
Not applicableUnknownNCT02992730What this trial is testingPredictors of Adjuvant Endocrine Therapy in Women With Breast CancerWho this might be right forBreast Cancer Female Georgetown University 630
Not applicableWithdrawnNCT01314508What this trial is testingIncrelex Treatment of Children With Chronic Liver Disease and Short StatureWho this might be right forGrowth FailureChronic Liver Disease University of California, Los Angeles
Not applicableEnrolling By InvitationNCT07128771What this trial is testingCardiomodulatory Effects of Gender-Affirming Hormone TherapyWho this might be right forGender IncongruenceCardiovascular Disease (CVD) Risk Factors University Hospital, Akershus 450
Testing effectiveness (Phase 2)Ended earlyNCT04738292What this trial is testingOnapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)Who this might be right forER-positive Breast CancerHER2-negative Breast CancerMetastatic Cancer University of Wisconsin, Madison 11
Not applicableUnknownNCT05070234What this trial is testingGenetic Diagnosis and Human Growth Hormone Treatment in Small for Gestational Age Children With Short StatureWho this might be right forSmall for Gestational Age InfantSilver-Russell SyndromeGenetic Diseases, Inborn Chunxiu Gong 150
Not applicableStudy completedNCT06498921What this trial is testingAn Observational Study to Learn More About the Use of Darolutamide as a Part of a Combination Therapy in Belgian Men With Metastatic Hormone-Sensitive Prostate Cancer in Routine Medical CareWho this might be right forMetastatic Hormone-sensitive Prostate Cancer Bayer 106
Testing effectiveness (Phase 2)WithdrawnNCT00057993What this trial is testingTrastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast CancerWho this might be right forBreast Cancer Northwestern University
Not applicableStudy completedNCT02782221What this trial is testingLipolytic Effects of GH in Human Subjects in VivoWho this might be right forMetabolic DiseasesGrowth Hormone Treatment University of Aarhus 9
Testing effectiveness (Phase 2)Study completedNCT00284752What this trial is testingPhase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate CancerWho this might be right forProstate Cancer Kaiser Permanente 56
Testing effectiveness (Phase 2)Study completedNCT03870399What this trial is testingStudy of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive ExpressionWho this might be right forNeuroendocrine TumorsProgesterone Receptor Positive TumorEstrogen Receptor Positive Tumor AC Camargo Cancer Center 23
Large-scale testing (Phase 3)Study completedNCT00295763What this trial is testingA New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.Who this might be right forDifferentiated Thyroid Cancer Genzyme, a Sanofi Company 61
Not applicableStudy completedNCT06003114What this trial is testingUnderstand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other OrgansWho this might be right forBreast Cancer Pfizer 472
Testing effectiveness (Phase 2)Study completedNCT01946165What this trial is testingAbiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and EnzalutamideWho this might be right forProstate Cancer M.D. Anderson Cancer Center 69
Large-scale testing (Phase 3)Ended earlyNCT00097344What this trial is testingThe CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerWho this might be right forBreast NeoplasmsNeoplasms, Hormone-Dependent Intarcia Therapeutics 842